Analysis of the efficacy of modified laparoscopic ureterobladder reimplantation in the treatment of ureterovaginal fistula
International Urology and Nephrology · 2025
DOI: 10.1007/s11255-025-04504-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Urology and Nephrology, 2025. Verfasst von Ruizhe Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, China. Hauptthemen laut MEDLINE: Laparoscopy, Replantation, Ureter, Ureteral Diseases. Die Arbeit nennt 12 Literaturangaben. Gefördert von: Clinical Research and Cultivation Plan Project of the Second Afliated Hospital of Anhui Medical University.
Abstract (Originalsprache)
OBJECTIVE: Analysis of technical improvements and efficacy of modified laparoscopic ureteral bladder reimplantation for the treatment of ureterovaginal fistula. METHODS: A retrospective analysis was conducted on clinical data from 20 patients who developed a ureterovaginal fistula due to gynecological surgeries and underwent modified laparoscopic ureteral bladder reimplantation at our hospital from September 2018 to May 2024. RESULTS: 20 patients with ureterovaginal fistula were included, with 9 cases on the left side, 9 on the right side, and 2 bilateral. The locations of the ureterovaginal fistulas were all in the distal ureter. The average age was 50.24 ± 5.22 years, and the average body mass index was 23.22 ± 3.98. The average duration of urine leakage before surgery was 12.20 ± 7.05 days. All surgeries were successful (20/20), with an average operation time of 140.85 ± 55.80 min, intraoperative blood loss of 14.50 ± 7.42 ml, and postoperative hospital stay of 8.24 ± 4.47 days. The ureteral stents were left in place for a mean duration of (51.50 ± 9.65) days postoperatively. No complications occurred after the surgery, and imaging follow-up at 9 months indicated that all patients had recovered well. CONCLUSION: Early diagnosis and treatment are essential for patients with ureterovaginal fistula. During the modified ureteral bladder reimplantation, it is crucial to ensure tension-free anastomosis without excessive dissection of the distal ureter. Laparoscopic ureteral bladder reimplantation is a reliable, safe, minimally invasive, and well-accepted surgical method, deserving of further promotion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, China.
- Department of Urology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, China. fanglu_uro@126.com.
- Department of Urology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, China. shineyangchao@126.com.
- Department of Urology, The Second Affiliated Hospital of Anhui Medical University, No. 678 Furong Road, Hefei, 230601, China. wangyi2035@ahmu.edu.cn.
Förderung
- Clinical Research and Cultivation Plan Project of the Second Afliated Hospital of Anhui Medical University
Zitieren
APA
Jiang, R., Jiang, C., Li, S., Zhu, T., Fang, L., Yang, C., & Wang, Y. (2025). Analysis of the efficacy of modified laparoscopic ureterobladder reimplantation in the treatment of ureterovaginal fistula. International Urology and Nephrology. https://doi.org/10.1007/s11255-025-04504-3
Vancouver
Jiang R, Jiang C, Li S, Zhu T, Fang L, Yang C, et al. Analysis of the efficacy of modified laparoscopic ureterobladder reimplantation in the treatment of ureterovaginal fistula. International Urology and Nephrology. 2025. doi:10.1007/s11255-025-04504-3
BibTeX
@article{Jiang2025,
author = {Jiang, Ruizhe and Jiang, Chao and Li, Shiji and Zhu, Tengfei and Fang, Lu and Yang, Chao and Wang, Yi},
title = {Analysis of the efficacy of modified laparoscopic ureterobladder reimplantation in the treatment of ureterovaginal fistula},
journal = {International Urology and Nephrology},
year = {2025},
doi = {10.1007/s11255-025-04504-3}
}
EUVIMED